Medicare Enrolled
Dr. Kimberly Radloff, M.D.
Dermatology · Marysville, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Radloff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Radloff?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Radloff
Dr. Kimberly Radloff is a dermatology specialist in Marysville, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Radloff performed 4,838 Medicare services across 2,632 unique beneficiaries.
Between the years covered by Open Payments, Dr. Radloff received a total of $14,437 from 53 pharmaceutical and/or device companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Radloff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 18% volume in OH
$14,437 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,838
Medicare services
Top 18% in OH for dermatology
2,632
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~302 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,917 | $5 | $11 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
770 | $58 | $155 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
509 | $35 | $111 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
478 | $61 | $174 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
249 | $70 | $221 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
190 | $76 | $190 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
154 | $36 | $89 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $37 | $96 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
91 | $62 | $192 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
76 | $100 | $420 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
48 | $289 | $738 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
47 | $110 | $279 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
39 | $285 | $689 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
30 | $47 | $168 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
26 | $99 | $434 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $93 | $287 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
23 | $65 | $294 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
21 | $228 | $521 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
19 | $347 | $816 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
18 | $40 | $124 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
13 | $130 | $479 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,437
Total received (2018-2024)
Avg $2,062/year across 7 years
Top 13% in OH for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
771
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,845 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$592 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,730
2023
$2,284
2022
$2,179
2021
$2,150
2020
$1,203
2019
$2,261
2018
$1,631
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dermavant Sciences, Inc.
$462
Janssen Biotech, Inc.
$398
ABBVIE INC.
$389
Novartis Pharmaceuticals Corporation
$209
Incyte Corporation
$195
UCB, Inc.
$184
MAYNE PHARMA COMMERCIAL LLC
$152
LEO Pharma Inc.
$104
GENZYME CORPORATION
$92
Arcutis Biotherapeutics, Inc.
$71
E.R. Squibb & Sons, L.L.C.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Galderma Laboratories, L.P.
$66
Smith+Nephew, Inc.
$47
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
PFIZER INC.
$40
Regeneron Healthcare Solutions, Inc.
$30
Krystal Biotech Inc
$25
Lilly USA, LLC
$23
Ortho Dermatologics, a division of Bausch Health US, LLC
$23
Organon Llc
$22
Verrica Pharmaceuticals Inc.
$15
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,579
Novartis Pharmaceuticals Corporation
$1,236
ABBVIE INC.
$1,058
PruGen, Inc. Pharmaceuticals
$1,027
Galderma Laboratories, L.P.
$807
Dermavant Sciences, Inc.
$736
Lilly USA, LLC
$636
AbbVie Inc.
$554
Sun Pharmaceutical Industries Inc.
$532
LEO Pharma Inc.
$494
Biofrontera Inc.
$457
UCB, Inc.
$455
GENZYME CORPORATION
$428
EPI Health, LLC
$393
Mayne Pharma Inc.
$347
Regeneron Healthcare Solutions, Inc.
$346
Incyte Corporation
$344
VYNE Pharmaceuticals Inc.
$308
Almirall LLC
$294
Ortho Dermatologics, a division of Bausch Health US, LLC
$252
MAYNE PHARMA COMMERCIAL LLC
$234
PFIZER INC.
$224
AbbVie, Inc.
$182
SUN PHARMACEUTICAL INDUSTRIES INC.
$130
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
Arcutis Biotherapeutics, Inc.
$119
Janssen Scientific Affairs, LLC
$94
Genentech USA, Inc.
$84
Journey Medical Corporation
$78
Encore Dermatology Inc.
$75
Smith+Nephew, Inc.
$72
E.R. Squibb & Sons, L.L.C.
$71
Verrica Pharmaceuticals Inc.
$62
DERMIRA, INC.
$62
MAYNE PHARMA INC.
$60
Celgene Corporation
$55
Exeltis, USA Inc.
$50
Amgen Inc.
$43
Organon LLC
$40
Bayer HealthCare Pharmaceuticals Inc.
$39
Fresenius Kabi USA, LLC
$30
Aclaris Therapeutics, Inc.
$28
Krystal Biotech Inc
$25
Taro Pharmaceuticals USA, Inc.
$24
Organon Llc
$22
Merck Sharp & Dohme LLC
$22
Merck Sharp & Dohme Corporation
$19
Medimetriks Pharmaceuticals, Inc.
$17
Allergan Inc.
$16
Mission Pharmacal Company
$16
TARO PHARMACEUTICALS USA, INC.
$13
Helsinn Therapeutics (U.S.), Inc.
$12
Glenmark Therapeutics Inc.
$12
Top 3 companies account for 26.8% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Aczone · Ameluz · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Ceracade · Cimzia · Cordran Tape · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Erivedge · FINACEA · Finacea · GRAFIX PL · HADLIMA · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · KEYTRUDA · Klisyri · LIBTAYO · Mupirocin Cream · Neo-Synalar · Neocera · Neosalus · OASIS · ONEXTON · OPZELURA · ORACEA · Otezla · PICATO · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · VALCHLOR · VTAMA · VYJUVEK · Veltin · Winlevi · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
28
Per 100K population
42.9
County median income
$109,506
Nearest hospital
MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Radloff is a clinical cardiology specialist, with above-average Medicare volume (top 18% in OH), with low-engagement industry engagement in the top 13% of OH peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Radloff experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Radloff performed 1,917 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Radloff receive payments from pharmaceutical companies?
Yes. Dr. Radloff received a total of $14,437 from 53 companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Radloff's costs compare to other dermatologists in Marysville?
Dr. Radloff's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Radloff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Marysville
Browse dermatologists in Marysville ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in OH
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in OH
Which OH dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology